Biktarvy is a prescription medication for patients diagnosed positive with HIV [herpes intensive virus] who are seeking a safe treatment. It is prescribed to both adults and children (according to body weight, 14 kgs) and guaranteed by the Food and Drug Administration [FDA] in the US.

But what all patients thus diagnosed need to know is the relative cost of the medicine in its original form. Its current price (and anyone seeking therapy is recommended to check for current prices at time of treatment) is estimated as being rather high, in contrast to generic versions and similar medications available.

The current price given for Biktarvy itself poses a risk to those patients. That included me. I was diagnosed positive in March, 2024*. At time of diagnosis, at the local clinic in my community, the doctor and staff on duty recommended Biktarvy, claiming safe and effective treatment.

I started by searching for comparative prices and the price aforementioned, according to the administrations concerned, posed a potential obstacle in my path, much like encountering a brick wall.

Therefore, I decided to contact the community for solutions. The support and suggestions offered proved to be a light shining brightly through the darkness. 

So, to get to the point, what all patients tested positive with HIV should know is the cost of the drug and what alternatives are available and at their relative prices.

For example, whereas in the United States, Biktarvy cost in India, which has become the new marketplace for this drug or its generic alternatives, the cost is considerably cheaper ($150 or less).

 The underlying cause for the expense in USA is patent, which is required by law. In addition, for the reason of profit, only the original product is available there. It has been demonstrated that when generic versions or alternatives are produced, the relative costs reduce considerably. That makes them more desirable.

There are several generic alternatives available and the sources provided with these items will list the current price per drug. It can never be over-emphasized that any patient with HIV should seek these sources and enquire and order from them. But there are a few questions and facts concerned with this issue.

To start with, you may ask the relative cost of Biktarvy without insurance coverage. There are insurance packages that provide coverage; but they are not available to all patients. However, anyone who proves eligible for the coverage should apply and use it to cover the cost of the drug. Regarding any challenges to this service, the patient should inquire in full detail and demand as much from the providers.

When inquiring, the potential buyer should further inquire whether the assistance program(s) available will actually reduce the cost to an affordable amount.

Many will.  Besides that, there are coupons and copay systems available from some of these pharmacies that help cover the cost of the drug for eligible patients.

It will prove very valuable to the patient concerned to investigate these for correct and useful information.

Another high option to look into is advocating lower prices for such drugs, because Biktarvy and its generic alternatives are highly needed.

I engaged my community at large in this way, after diagnosis. I was certain to give full details and attention to my questions, to insure that those available to respond would provide equally full answers. It cannot be overlooked that detailed description and information should be provided, for the benefit of those concerned.

My experience was a bit exasperating but very informative and useful in the long run. I can and must suggest this procedure to anyone diagnosed positive with HIV, who desires a safe and effective treatment, and relief from the infection.

The best choice for online pharmaceutical assistance, for me at least, is Sunny Pharma